aetherAI vs Ibex Medical Analytics
Two computational pathology companies built outside the United States that both now hold permissions in more than one market. Ibex detects cancer, with prostate, breast and gastric solutions in routine clinical use, United States clearance as an in vitro diagnostic for the prostate product, peer reviewed publication and the most complete published certification set of any vendor in this index. aetherAI spans anatomical pathology and haematology, hosts third party algorithms alongside its own, and secured both a United States clearance and European certification for its image management platform in 2026. For a laboratory buying cancer detection with the strongest assurance record behind it, Ibex. For one wanting a platform that covers haematology as well and hosts other vendors' algorithms, aetherAI reaches wider. Check which permission applies in your market before either.
- The certification set is the most complete of any vendor in this index and the deployment evidence is verifiable through third parties rather than vendor claims.
- The cleared indication is conservative and well constructed, which is the right posture for software flagging cancer on a slide a pathologist will sign.
- Three cancer types are in routine clinical use worldwide with peer reviewed publication behind the deployment scale.
- It spans anatomical pathology and haematology rather than one domain, with training scale disclosed for the haematology product.
- The image management platform secured both a United States clearance and European certification in 2026, which is a genuine dual market position.
- The platform hosts diagnostic algorithms rather than only running its own, so a laboratory gets infrastructure and applications from one vendor.
Side by Side
| Axis | A aetherAI |
I Ibex Medical Analytics |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Read the regulatory footprint by market rather than by company, since a product usable for diagnosis in one jurisdiction may be research use only in another, and both vendors hold different permissions in different places. aetherAI publishes no health privacy statement, business associate terms, hosting detail or subgroup analysis. Neither vendor imposes a published performance requirement on third party algorithms it distributes. Staining and scanner variation between laboratories remains the largest uncontrolled variable for any model either platform runs.